SAN DIEGO, Aug. 11, 2011 (GLOBE NEWSWIRE) – Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, was interviewed recently by the CEO Roadshow financial network (http://www.ceoroadshow/).
During the interview, Dr. Damaj reported on plans for the Company’s pipeline, including the proposed commercialization in Canada and Europeof Vitaros®, a topical treatment for erectile dysfunction.
Disclaimer